Effects of a gluco-oligosaccharide supplement on the morphological characteristics of the gastro-intestinal tract and growth performance in weaned piglets

Abstract

This study was designed to evaluate the effects of a gluco-oligosaccharide (GOS), as an alternative to growth promoters in piglets, on: growth performance, blood parameters and morphological characteristics of the intestinal tract. Four week old weaned piglets (n=128) (7.2 ± 1.04 kg l.w.) were divided into four groups and fed for 77 days on different diets as follows: 1.- Basal diet (CTR); 2.- Basal diet supplemented with a 2% GOS; 3.- Basal diet supplemented with chlortetracycline and spiramicine at 1000 and 400 mg/kg, respectively, for 14 days and then fed the CTR basal diet (CTRM); or 4.-a GOS diet supplemented and administered as in group 3 (GOSM). Animals were individually weighed 5 times, on days 0, 14, 35, 56 and 77. At the same time, the feed intake and average daily gains (ADG) were recorded and the feed conversion ratio (FCR) was calculated. On days 0 and 77, plasma was sampled from 6 piglets/treatment group, whereas on 77th day, 4 piglets/treatment were slaughtered to assess the morphological characteristics of parts of their gastro-intestinal tracts (ileum and caecum). The results showed no effects of the medications on the ADG in all the experimental periods. However, from days 57 to 77 of the trial period, the ADG was found to be higher in the GOS-fed animals (P=0.0747). During the first 14 days of the trial, the piglets on the medicated diets showed a higher intake than the animals in the normal diet groups, but no differences were detectable in the FCR. The globulin concentration and the albumin/globulin ratio was found to be reduced by GOS treatment (P <0.01). The urea concentration in the blood was decreased (P<0.05), whereas the plasma concentration of phosphorous was increased (P<0.01), by GOS supplementation. We found that the heights of the villi in the ileum was higher in the piglets on the GOSM diet compared to CTRM diet: (188.66 mm vs 255.74 mm; P<0.01). We also observed that supplementing these diets with GOS lead to a higher caecum epithelial cell height (11.7 μm vs 14.7 μm; P 0.068) compared with animals on the non-supplemented diets. Our current data indicate that the growth performance did not differ between piglets fed on control, antibiotic-supplemented or GOS-supplemented diets. A dietary supplementation of GOS does increase the villus length, but only in animals previously fed with medicated feeds. The use of GOS seems to exert anti-inflammatory effects upon these animals.